Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

COVID-19 can cause significant hair loss.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Social media data can help track and predict COVID-19 symptoms and trends.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The pandemic changed how often certain skin conditions were diagnosed.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Vaccination and timely treatment reduce the risk of long COVID.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

COVID-19 infection may cause hair loss.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.